| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Culwell Kelly is a Chief Medical Officer at Evofem Biosciences, Inc.. Recent SEC Form 4 filings include 1 buy and 4 sells.
Estimated insider holdings value: $2K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 1, 2020 | EVFM Evofem Biosciences, Inc. | Chief Medical Officer | Sell | 2,000 | $4.71 | $9,410.00 | -0.5% | |
| Feb 19, 2020 | EVFM Evofem Biosciences, Inc. | Chief Medical Officer | Sell | 1,000 | $7.00 | $7,000.00 | -0.5% | |
| Dec 2, 2019 | EVFM Evofem Biosciences, Inc. | Chief Medical Officer | Sell | 1,000 | $7.35 | $7,350.00 | -2.2% | |
| Aug 16, 2018 | EVFM Evofem Biosciences, Inc. | Chief Medical Officer | Buy | 3,000 | $2.24 | $6,720.00 | +33.4% |